166 related articles for article (PubMed ID: 38310502)
1. Clinicopathologic Characteristics, Etiologies, and Outcome of Secondary Oxalate Nephropathy.
Nasr SH; Valeri AM; Said SM; Sethi S; Nath KA; Lieske JC; Bu L
Mayo Clin Proc; 2024 Apr; 99(4):593-606. PubMed ID: 38310502
[TBL] [Abstract][Full Text] [Related]
2. Etiologies, Clinical Features, and Outcome of Oxalate Nephropathy.
Buysschaert B; Aydin S; Morelle J; Gillion V; Jadoul M; Demoulin N
Kidney Int Rep; 2020 Sep; 5(9):1503-1509. PubMed ID: 32954074
[TBL] [Abstract][Full Text] [Related]
3. Clinical Outcomes and Histological Patterns in Oxalate Nephropathy due to Enteric and Nonenteric Risk Factors.
Reddy S; Bolen E; Abdelmalek M; Lieske JC; Ryan M; Keddis MT
Am J Nephrol; 2021; 52(12):961-968. PubMed ID: 34844241
[TBL] [Abstract][Full Text] [Related]
4. A hidden cause of oxalate nephropathy: a case report.
Mahmoud T; Ghandour EC; Jaar BG
J Med Case Rep; 2021 Mar; 15(1):106. PubMed ID: 33678172
[TBL] [Abstract][Full Text] [Related]
5. Recurrence of Hyperoxaluria and Kidney Disease after Combined Intestine-Kidney Transplantation for Enteric Hyperoxaluria.
Ekser B; Mangus RS; Kubal CA; Fridell JA; Powelson JA; Nagaraju S; Mihaylov P; Phillips CL; Saxena R; Goggins WC
Am J Nephrol; 2016; 44(2):85-91. PubMed ID: 27410399
[TBL] [Abstract][Full Text] [Related]
6. Secondary oxalate nephropathy and kidney transplantation.
Aziz F; Jorgenson M; Garg N
Curr Opin Organ Transplant; 2023 Feb; 28(1):15-21. PubMed ID: 36342385
[TBL] [Abstract][Full Text] [Related]
7. Purslane-induced oxalate nephropathy: case report and literature review.
Wang X; Zhang X; Wang L; Zhang R; Zhang Y; Cao L
BMC Nephrol; 2023 Jul; 24(1):207. PubMed ID: 37443012
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of de novo allograft diabetic nephropathy in renal allograft recipients.
Prasad N; Gupta P; Jain M; Bhadauria D; Gupta A; Sharma RK; Kaul A
Exp Clin Transplant; 2013 Jun; 11(3):215-21. PubMed ID: 23767942
[TBL] [Abstract][Full Text] [Related]
9. [Oxalate nephropathy: a new entity of acute kidney injury in diabetic patients?].
Muji A; Moll S; Saudan P
Rev Med Suisse; 2015 Feb; 11(463):493-4, 496-8. PubMed ID: 25898457
[TBL] [Abstract][Full Text] [Related]
10. Secondary Oxalate Nephropathy: Causes and Clinicopathological Characteristics of a Case Series.
Liang S; Li L; Chen D; Liang D; Xu F; Cheng Z; Abuduwupuer Z; Zhang C; Zhang M; Zeng C
Nephron; 2021; 145(6):684-691. PubMed ID: 34237750
[TBL] [Abstract][Full Text] [Related]
11. Reversal of Roux-en-Y Gastric Bypass for Successful Salvage of Renal Allograft.
Hrebinko K; Moroni E; Ganoza A; Puttarajappa CM; Molinari M; Sood P; El Hag M; Wijkstrom M; Tevar AD
Am Surg; 2023 Apr; 89(4):1286-1289. PubMed ID: 33631945
[TBL] [Abstract][Full Text] [Related]
12. Acute oxalate nephropathy causing late renal transplant dysfunction due to enteric hyperoxaluria.
Rankin AC; Walsh SB; Summers SA; Owen MP; Mansell MA
Am J Transplant; 2008 Aug; 8(8):1755-8. PubMed ID: 18557738
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic insufficiency as a complication of type 1 diabetes causing enteric hyperoxaluria in a transplant kidney.
Chambers J; Appleton A; Dudley C
BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35787489
[TBL] [Abstract][Full Text] [Related]
14. Oxalate nephropathy in systemic sclerosis: Case series and review of the literature.
Ligon CB; Hummers LK; McMahan ZH
Semin Arthritis Rheum; 2015 Dec; 45(3):315-20. PubMed ID: 26239907
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology and Management of Hyperoxaluria and Oxalate Nephropathy: A Review.
Demoulin N; Aydin S; Gillion V; Morelle J; Jadoul M
Am J Kidney Dis; 2022 May; 79(5):717-727. PubMed ID: 34508834
[TBL] [Abstract][Full Text] [Related]
16. Determinants and impact of calcium oxalate crystal deposition on renal outcomes in acute kidney injury patients.
Yang W; Zhao T; Chen X; Wang S; Wang Y; Su T
Ren Fail; 2024 Dec; 46(1):2334396. PubMed ID: 38570195
[TBL] [Abstract][Full Text] [Related]
17. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass.
Nelson WK; Houghton SG; Milliner DS; Lieske JC; Sarr MG
Surg Obes Relat Dis; 2005; 1(5):481-5. PubMed ID: 16925274
[TBL] [Abstract][Full Text] [Related]
18. Reversal of Gastric Bypass Resolves Hyperoxaluria and Improves Oxalate Nephropathy Secondary to Roux-en-Y Gastric Bypass.
Agrawal V; Wilfong JB; Rich CE; Gibson PC
Case Rep Nephrol Dial; 2016; 6(3):114-119. PubMed ID: 27781207
[TBL] [Abstract][Full Text] [Related]
19. "Green Smoothie Cleanse" Causing Acute Oxalate Nephropathy.
Makkapati S; D'Agati VD; Balsam L
Am J Kidney Dis; 2018 Feb; 71(2):281-286. PubMed ID: 29203127
[TBL] [Abstract][Full Text] [Related]
20. Kidney transplant dysfunction in a patient with COVID - 19 infection: role of concurrent Sars-Cov 2 nephropathy, chronic rejection and vitamin C-mediated hyperoxalosis: case report.
Anandh U; Gowrishankar S; Sharma A; Salama A; Dasgupta I
BMC Nephrol; 2021 Mar; 22(1):91. PubMed ID: 33722190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
